Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Genetic Polymorphisms of Superoxide Dismutase Locus of Pneumocystis jirovecii in Spanish Population.

Morilla R, González-Magaña A, Friaza V, de Armas Y, Medrano FJ, Calderón EJ, de la Horra C.

Front Public Health. 2019 Oct 15;7:292. doi: 10.3389/fpubh.2019.00292. eCollection 2019.

2.

An analysis of the false negative rate of minimal residual disease measurement by multiparameter flow cytometry in multiple myeloma.

Austin M, O'Connor S, Morilla R, Pawlyn C, Kaiser MF, Boyd KD.

Int J Lab Hematol. 2019 Sep 20. doi: 10.1111/ijlh.13112. [Epub ahead of print] No abstract available.

PMID:
31539199
3.

Airborne acquisition of Pneumocystis in bronchoscopy units: a hidden danger to healthcare workers.

Morilla R, Martínez-Rísquez MT, de la Horra C, Friaza V, Martín-Juan J, Romero B, Conde M, Varela JM, Calderón EJ, Medrano FJ.

Med Mycol. 2018 Oct 4. doi: 10.1093/mmy/myy093. [Epub ahead of print]

PMID:
30289486
4.

Inter-laboratory validation of a harmonized PNH flow cytometry assay.

Payne D, Johansson U, Bloxham D, Couzens S, Carter A, Holtom P, Baker B, Hughes M, Knill T, Milne T, Morilla A, Morilla R, O'Brien D, Thomas L.

Cytometry B Clin Cytom. 2018 Sep;94(5):580-587. doi: 10.1002/cyto.b.21726.

5.

The use of unfixed bone marrow trephines for multicolour flow cytometry.

Morilla R, Moss K, Nikolova V, Marquardt K, Duke S, Adamowska K, Fuller L, Taifoor A, Johnson N, Zeisig A, Morilla A, Atra A, Taussig DC.

Methods. 2018 Feb 1;134-135:80-86. doi: 10.1016/j.ymeth.2017.12.014. Epub 2017 Dec 21. Review.

PMID:
29274873
6.

The morphology of CLL revisited: the clinical significance of prolymphocytes and correlations with prognostic/molecular markers in the LRF CLL4 trial.

Oscier D, Else M, Matutes E, Morilla R, Strefford JC, Catovsky D.

Br J Haematol. 2016 Sep;174(5):767-75. doi: 10.1111/bjh.14132. Epub 2016 May 6.

7.

Harmonemia: a universal strategy for flow cytometry immunophenotyping-A European LeukemiaNet WP10 study.

Lacombe F, Bernal E, Bloxham D, Couzens S, Porta MG, Johansson U, Kern W, Macey M, Matthes T, Morilla R, Paiva A, Palacio C, Preijers F, Ratei R, Siitonen S, Allou K, Porwit A, Béné MC.

Leukemia. 2016 Aug;30(8):1769-72. doi: 10.1038/leu.2016.44. Epub 2016 Feb 29. No abstract available.

PMID:
26922887
8.

Green-grey crystals in acute myeloid leukaemia.

Sud A, Morilla R, Ethell M, Taussig D, Liapis K.

Br J Haematol. 2015 Mar;168(5):618. doi: 10.1111/bjh.13244. Epub 2014 Nov 27. No abstract available.

PMID:
25430484
9.

The impact of long-term lenalidomide exposure on the cellular composition of bone marrow.

Brioli A, Melchor L, Titley I, Vijayaraghavan G, Stephens C, Zeisig A, Pawlyn C, Cavo M, Morilla R, Davies FE, Morgan GJ.

Leuk Lymphoma. 2014 Nov;55(11):2665-8. doi: 10.3109/10428194.2014.900765. Epub 2014 Apr 22. No abstract available.

PMID:
24660850
10.

Guidelines on the use of multicolour flow cytometry in the diagnosis of haematological neoplasms. British Committee for Standards in Haematology.

Johansson U, Bloxham D, Couzens S, Jesson J, Morilla R, Erber W, Macey M; British Committee for Standards in Haematology.

Br J Haematol. 2014 May;165(4):455-88. doi: 10.1111/bjh.12789. Epub 2014 Mar 13. No abstract available.

11.

Pre-transplant MRD predicts outcome following reduced-intensity and myeloablative allogeneic hemopoietic SCT in AML.

Anthias C, Dignan FL, Morilla R, Morilla A, Ethell ME, Potter MN, Shaw BE.

Bone Marrow Transplant. 2014 May;49(5):679-83. doi: 10.1038/bmt.2014.9. Epub 2014 Feb 10.

PMID:
24510069
12.

High prevalence of Pneumocystis jirovecii colonization in Brazilian cystic fibrosis patients.

Pederiva MA, Wissmann G, Friaza V, Morilla R, de La Horra C, Montes-Cano MA, Goldani LZ, Calderón EJ, Prolla JC.

Med Mycol. 2012 Jul;50(5):556-60. doi: 10.3109/13693786.2011.645892. Epub 2011 Dec 29.

PMID:
22206262
13.

Immunohistochemical distinction of haematogones from B lymphoblastic leukaemia/lymphoma or B-cell acute lymphoblastic leukaemia (B-ALL) on bone marrow trephine biopsies: a study on 62 patients.

Al-Shieban S, Byrne E, Trivedi P, Morilla R, Matutes E, Naresh KN.

Br J Haematol. 2011 Aug;154(4):466-70. doi: 10.1111/j.1365-2141.2011.08760.x. Epub 2011 Jul 2.

PMID:
21722099
14.

Pneumocystis jirovecii colonization in patients treated with infliximab.

Wissmann G, Morilla R, Martín-Garrido I, Friaza V, Respaldiza N, Povedano J, Praena-Fernández JM, Montes-Cano MA, Medrano FJ, Goldani LZ, de la Horra C, Varela JM, Calderón EJ.

Eur J Clin Invest. 2011 Mar;41(3):343-8. doi: 10.1111/j.1365-2362.2010.02415.x. Epub 2010 Nov 12.

PMID:
21299548
15.

Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification.

Matutes E, Pickl WF, Van't Veer M, Morilla R, Swansbury J, Strobl H, Attarbaschi A, Hopfinger G, Ashley S, Bene MC, Porwit A, Orfao A, Lemez P, Schabath R, Ludwig WD.

Blood. 2011 Mar 17;117(11):3163-71. doi: 10.1182/blood-2010-10-314682. Epub 2011 Jan 12.

PMID:
21228332
16.

High prevalence of Pneumocystis jiroveci colonization among young HIV-infected patients.

Gutiérrez S, Morilla R, León JA, Martín-Garrido I, Rivero L, Friaza V, Respaldiza N, Montes-Cano MA, Terán R, de la Horra C.

J Adolesc Health. 2011 Jan;48(1):103-5. doi: 10.1016/j.jadohealth.2010.05.013. Epub 2010 Aug 24.

PMID:
21185532
17.

Pneumocystis jiroveci dihydropteroate synthase gene mutations among colonized individuals and Pneumocystis pneumonia patients from Spain.

Friaza V, Morilla R, Respaldiza N, de la Horra C, Calderón EJ.

Postgrad Med. 2010 Nov;122(6):24-8. doi: 10.3810/pgm.2010.11.2219.

PMID:
21084778
18.

[Human reservoirs of Pneumocystis].

Wissmann G, Morilla R, Friaza V, Calderón E, Varela JM.

Enferm Infecc Microbiol Clin. 2010 Jan;28(1):38-43. doi: 10.1016/j.eimc.2008.07.008. Epub 2009 Apr 29. Review. Spanish.

PMID:
19403207
19.

Prevalence of dihydropteroate synthase mutations in Spanish patients with HIV-associated Pneumocystis pneumonia.

Friaza V, Montes-Cano MA, Respaldiza N, Morilla R, Calderón EJ, de la Horra C.

Diagn Microbiol Infect Dis. 2009 May;64(1):104-5; author reply 106-7. doi: 10.1016/j.diagmicrobio.2009.01.015. Epub 2009 Feb 18. No abstract available.

PMID:
19232864
20.

Combinations of ZAP-70, CD38 and IGHV mutational status as predictors of time to first treatment in CLL.

Morilla A, Gonzalez de Castro D, Del Giudice I, Osuji N, Else M, Morilla R, Brito Babapulle V, Rudenko H, Matutes E, Dearden C, Catovsky D, Morgan GJ.

Leuk Lymphoma. 2008 Nov;49(11):2108-15. doi: 10.1080/10428190802360810.

PMID:
19021053
21.

Pneumocystis jirovecii transmission from immunocompetent carriers to infant.

Rivero L, de la Horra C, Montes-Cano MA, Rodríguez-Herrera A, Respaldiza N, Friaza V, Morilla R, Gutiérrez S, Varela JM, Medrano FJ, Calderón EJ.

Emerg Infect Dis. 2008 Jul;14(7):1116-8. doi: 10.3201/eid1407.071431.

22.

Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders.

Rawstron AC, Orfao A, Beksac M, Bezdickova L, Brooimans RA, Bumbea H, Dalva K, Fuhler G, Gratama J, Hose D, Kovarova L, Lioznov M, Mateo G, Morilla R, Mylin AK, Omedé P, Pellat-Deceunynck C, Perez Andres M, Petrucci M, Ruggeri M, Rymkiewicz G, Schmitz A, Schreder M, Seynaeve C, Spacek M, de Tute RM, Van Valckenborgh E, Weston-Bell N, Owen RG, San Miguel JF, Sonneveld P, Johnsen HE; European Myeloma Network.

Haematologica. 2008 Mar;93(3):431-8. doi: 10.3324/haematol.11080. Epub 2008 Feb 11.

23.

Systemic inflammation in patients with chronic obstructive pulmonary disease who are colonized with Pneumocystis jiroveci.

Calderón EJ, Rivero L, Respaldiza N, Morilla R, Montes-Cano MA, Friaza V, Muñoz-Lobato F, Varela JM, Medrano FJ, Horra Cde L.

Clin Infect Dis. 2007 Jul 15;45(2):e17-9. Epub 2007 Jun 6.

PMID:
17578770
24.

Case 35: an unusual haematological neoplasm characterized by cells with cytoplasmic tails.

Kassam S, Rice A, Morilla R, Bain BJ.

Leuk Lymphoma. 2007 Jun;48(6):1208-10.

PMID:
17577785
25.

Cytogenetic abnormalities additional to t(11;14) correlate with clinical features in leukaemic presentation of mantle cell lymphoma, and may influence prognosis: a study of 60 cases by FISH.

Parry-Jones N, Matutes E, Morilla R, Brito-Babapulle V, Wotherspoon A, Swansbury GJ, Catovsky D.

Br J Haematol. 2007 Apr;137(2):117-24.

PMID:
17391491
26.

Zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia.

Del Giudice I, Morilla A, Osuji N, Matutes E, Morilla R, Burford A, Maravelaki S, Owusu-Ankomah K, Swansbury J, A'Hern R, Brito-Babapulle V, Catovsky D.

Cancer. 2005 Nov 15;104(10):2124-32.

27.

CD52 expression in T-cell large granular lymphocyte leukemia--implications for treatment with alemtuzumab.

Osuji N, Del Giudice I, Matutes E, Morilla A, Owusu-Ankomah K, Morilla R, Dunlop A, Catovksy D.

Leuk Lymphoma. 2005 May;46(5):723-7.

PMID:
16019510
28.

The leukemic presentation of mantle-cell lymphoma: disease features and prognostic factors in 58 patients.

Matutes E, Parry-Jones N, Brito-Babapulle V, Wotherspoon A, Morilla R, Atkinson S, Elnenaei MO, Jain P, Giustolisi GM, A'Hern RP, Catovsky D.

Leuk Lymphoma. 2004 Oct;45(10):2007-15.

PMID:
15370245
29.

Teaching cases from the Royal Marsden and St Mary's Hospitals. Case 24: striking lymphocytosis in a 2-year-old girl.

Gattens M, Morilla R, Bain BJ.

Leuk Lymphoma. 2004 Apr;45(4):851-2. No abstract available.

PMID:
15160972
30.

Isolated bone marrow involvement in diffuse large B cell lymphoma: a report of three cases with review of morphological, immunophenotypic and cytogenetic findings.

Alvares CL, Matutes E, Scully MA, Swansbury J, Min T, Gruszka-Westwood AM, Atkinson S, Hilditch B, Morilla R, Wotherspoon AC, Catovsky D.

Leuk Lymphoma. 2004 Apr;45(4):769-75.

PMID:
15160954
31.

CD38 expression as a prognostic indicator in chronic lymphocytic leukaemia.

Thornton PD, Fernandez C, Giustolisi GM, Morilla R, Atkinson S, A'Hern RP, Matutes E, Catovsky D.

Hematol J. 2004;5(2):145-51.

PMID:
15048065
32.

The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes.

Del Giudice I, Matutes E, Morilla R, Morilla A, Owusu-Ankomah K, Rafiq F, A'Hern R, Delgado J, Bazerbashi MB, Catovsky D.

Haematologica. 2004 Mar;89(3):303-8.

33.

Characterisation of TP53 abnormalities in chronic lymphocytic leukaemia.

Thornton PD, Gruszka-Westwood AM, Hamoudi RA, Atkinson S, Kaczmarek P, Morilla RM, Hilditch BL, A'Hern R, Matutes E, Catovsky D.

Hematol J. 2004;5(1):47-54.

PMID:
14745430
34.

Diagnostic significance of CD20 and FMC7 expression in B-cell disorders.

Delgado J, Matutes E, Morilla AM, Morilla RM, Owusu-Ankomah KA, Rafiq-Mohammed F, del Giudice I, Catovsky D.

Am J Clin Pathol. 2003 Nov;120(5):754-9.

PMID:
14608903
35.

[Chronic lymphoproliferative syndromes in Chile. A prospective study in 132 patients].

Cabrera ME, Marinov N, Guerra C, Morilla R, Matutes E.

Rev Med Chil. 2003 Mar;131(3):291-8. Spanish.

PMID:
12790078
36.
37.

Detection of cyclin D1 in B cell lymphoproliferative disorders by flow cytometry.

Jain P, Giustolisi GM, Atkinson S, Elnenaei MO, Morilla R, Owusu-Ankomah K, Rafiq-Mohammed F, Matutes E, Wotherspoon A, Catovsky D.

J Clin Pathol. 2002 Dec;55(12):940-5.

38.

p53 and mdm2 in mantle cell lymphoma in leukemic phase.

Solenthaler M, Matutes E, Brito-Babapulle V, Morilla R, Catovsky D.

Haematologica. 2002 Nov;87(11):1141-50.

39.

The T-lineage-affiliated CD2 gene lies within an open chromatin environment in acute promyelocytic leukemia cells.

Grimwade D, Outram SV, Flora R, Ings SJ, Pizzey AR, Morilla R, Craddock CF, Linch DC, Solomon E.

Cancer Res. 2002 Aug 15;62(16):4730-5.

40.

CD34 and CD117 are overexpressed in AML and may be valuable to detect minimal residual disease.

Scolnik MP, Morilla R, de Bracco MM, Catovsky D, Matutes E.

Leuk Res. 2002 Jul;26(7):615-9.

PMID:
12008077
41.

Immunophenotype changes and loss of CD52 expression in two patients with relapsed T-cell prolymphocytic leukaemia.

Tuset E, Matutes E, Brito-Babapulle V, Morilla R, Catovsky D.

Leuk Lymphoma. 2001 Nov-Dec;42(6):1379-83.

PMID:
11911422
42.

High-affinity binding sites for heparin generated on leukocytes during apoptosis arise from nuclear structures segregated during cell death.

Gebska MA, Titley I, Paterson HF, Morilla RM, Davies DC, Gruszka-Westwood AM, Kakkar VV, Eccles S, Scully MF.

Blood. 2002 Mar 15;99(6):2221-7.

PMID:
11877301
43.

Lymphogram: a rapid flow cytometry method for screening patients with lymphocytosis.

Giustolisi GM, Gruszka-Westwood AM, Morilla RM, Matutes E.

Haematologica. 2001 Nov;86(11):1223-4. No abstract available.

44.

Deletions of D13S25, D13S319 and RB-1 mapping to 13q14.3 in T-cell prolymphocytic leukaemia.

Brito-Babapulle V, Baou M, Matutes E, Morilla R, Atkinson S, Catovsky D.

Br J Haematol. 2001 Aug;114(2):327-32.

PMID:
11529851
45.

The effect of peripheral blood lymphocyte stimulation on zeta chain expression and IL-2 production in Hodgkin's disease.

Frydecka I, Boćko D, Kosmaczewska A, Ciszak L, Morilla R.

Br J Cancer. 2001 May 18;84(10):1339-43.

46.

Cyclin D1 by flow cytometry as a useful tool in the diagnosis of B-cell malignancies.

Elnenaei MO, Jadayel DM, Matutes E, Morilla R, Owusu-Ankomah K, Atkinson S, Titley I, Mandala EM, Catovsky D.

Leuk Res. 2001 Feb;25(2):115-23.

PMID:
11166826
47.

Quantitative expression of CD23 and its ligand CD21 in chronic lymphocytic leukemia.

Lopez-Matas M, Rodriguez-Justo M, Morilla R, Catovsky D, Matutes E.

Haematologica. 2000 Nov;85(11):1140-5.

48.

Expression of signal-transducing zeta chain in peripheral blood T cells and natural killer cells in patients with Hodgkin's disease in different phases of the disease.

Frydecka I, Kaczmarek P, Boćko D, Kosmaczewska A, Morilla R, Catovsky D.

Leuk Lymphoma. 1999 Nov;35(5-6):545-54.

PMID:
10609792
49.

Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders.

Cabezudo E, Carrara P, Morilla R, Matutes E.

Haematologica. 1999 May;84(5):413-8.

50.

Levels of expression of CD19 and CD20 in chronic B cell leukaemias.

Ginaldi L, De Martinis M, Matutes E, Farahat N, Morilla R, Catovsky D.

J Clin Pathol. 1998 May;51(5):364-9.

Supplemental Content

Loading ...
Support Center